Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ashton E. Beggs"'
Publikováno v:
Currents in Pharmacy Teaching and Learning. 8:634-639
Objectives To implement a pillbox simulation project and evaluate change in student pharmacists’ perceptions of medication adherence as indicated by pre-simulation and post-simulation survey responses. Methods Two colleges of pharmacy implemented a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4191a9095d1f2bc131d04fbad9bec36
https://doi.org/10.1016/j.cptl.2016.05.002
https://doi.org/10.1016/j.cptl.2016.05.002
Publikováno v:
American Journal of Health-System Pharmacy. 73:441-450
Purpose The mechanism of action, pharmacodynamics, pharmacokinetics, clinical efficacy, interaction potential, adverse effects, and place in therapy of panobinostat are reviewed. Summary Panobinostat (Farydak, Novartis) is a novel pan-deacetylase inh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c89531ecaca833e674c3ac8dbe60d56
https://doi.org/10.2146/ajhp150487
https://doi.org/10.2146/ajhp150487
Autor:
Allison C. Karst, Ashton E. Beggs
Publikováno v:
Journal of Health Care for the Poor and Underserved. 27:954-960
Objectives. To assess the effectiveness of pharmacy student-led education in adults experiencing homelessness. Methods. Five groups of pharmacy students each developed three Bingo games focused on a primary care health topic (asthma, diabetes, hyperl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3d64a06e36cff6772ff73eee6b71867
https://doi.org/10.1353/hpu.2016.0125
https://doi.org/10.1353/hpu.2016.0125
Vedolizumab: An integrin-receptor antagonist for treatment of Crohn’s disease and ulcerative colitis
Publikováno v:
American Journal of Health-System Pharmacy. 72:1271-1278
Purpose The pharmacology, pharmacokinetics, safety, efficacy, and dosing recommendations of vedolizumab, an integrin-receptor antagonist for the treatment of Crohn’s disease (CD) and ulcerative colitis (UC), are reviewed. Summary Vedolizumab is an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc90e43fd6871b7190e1ea16d92da5e4
https://doi.org/10.2146/ajhp140449
https://doi.org/10.2146/ajhp140449
Publikováno v:
Family medicine. 45(2)
This study evaluated a change in immunization rates and medical resident knowledge following an educational intervention. Differences in immunization rates based on resident or patient characteristics were also assessed.This pre- and post-interventio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fa0f4d3a93e5c8d7f0700290dd70171d
https://pubmed.ncbi.nlm.nih.gov/23378079
https://pubmed.ncbi.nlm.nih.gov/23378079
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 69(13)
Purpose Two cases of malignant hyperthermia suspected to be related to the use of a nondepolarizing neuromuscular blocker are reported. Summary A pharmacogenetic disorder that may occur in as many as 1 in 3000 anesthesia procedures, malignant hyperth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89eaf050d9631eb9db8b1d9fabae6a23
https://pubmed.ncbi.nlm.nih.gov/23135556
https://pubmed.ncbi.nlm.nih.gov/23135556
Publikováno v:
American Journal of Health-System Pharmacy. 69:2147-2148
Purpose A case of leukopenia in a patient receiving colchicine for calcium pyrophosphate dihydrate deposition disease, or pseudogout, is reported. Summary An 85-year-old man experienced leukopenia likely due to colchicine. His medical history include
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e3781fb614d251650a1fa1116499428
https://doi.org/10.2146/ajhp120330
https://doi.org/10.2146/ajhp120330
Autor:
Jennifer Quinn McCann, Ashton E. Beggs
Publikováno v:
American Journal of Health-System Pharmacy. 69:1945-1946
We thank Drs. Schuster and Johannsen for their interest in these complex cases and concur that there were several possible etiologies for the described reactions. We addressed these in the discussion portion of our report. Although the use of genetic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0145f46de276c4375dbf9f0723dd6236
https://doi.org/10.2146/ajhp120511
https://doi.org/10.2146/ajhp120511
Autor:
Wahaib, Kristy1 kristy.wahaib@belmont.edu, Beggs, Ashton E.1, Campbell, Hope1, Kodali, Leela1, Ford, Patrick D.2
Publikováno v:
American Journal of Health-System Pharmacy. 4/1/2016, Vol. 73 Issue 7, p441-450. 10p. 2 Charts.
Publikováno v:
American Journal of Health-System Pharmacy. 7/1/2012, Vol. 69 Issue 13, p1128-1134. 7p. 1 Graph.